Related Experiment Videos
Initial combination therapy compared with monotherapy in diabetic hypertensive patients
James R Sowers1, Guido Lastra, Ricardo Rocha
1Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia, MO, USA. sowersj@health.missouri.edu
Journal of Clinical Hypertension (Greenwich, Conn.)
|October 11, 2008
Summary
Combination therapy with valsartan and hydrochlorothiazide is more effective for lowering systolic blood pressure (SBP) in hypertensive patients, especially those with diabetes, compared to monotherapy.
Area of Science:
- Cardiology
- Pharmacology
- Endocrinology
Background:
- Hypertension management in diabetic patients is complex.
- Angiotensin receptor blockers (ARBs) and diuretics are common antihypertensives.
- Optimizing combination therapy initiation is crucial for achieving blood pressure goals.
Purpose of the Study:
- To compare the efficacy of valsartan monotherapy versus combination therapy with hydrochlorothiazide in diabetic and nondiabetic hypertensive patients.
- To determine optimal initiation strategies for combination therapy in hypertensive patients with diabetes.
Main Methods:
- Subgroup analyses from 3 randomized clinical trials.
- Comparison of systolic blood pressure (SBP) reduction between monotherapy and combination therapy.
- Multivariate models to predict goal SBP achievement (<130 mm Hg).
Main Results:
- Comparable SBP reductions were observed between diabetic and nondiabetic cohorts in 2 of 3 trials.
- Combination therapy demonstrated superior blood pressure-lowering efficacy across all 3 studies.
- Diabetic patients initiating combination therapy had a higher probability of reaching goal SBP.
Conclusions:
- Combination therapy with valsartan and hydrochlorothiazide offers greater SBP reduction than monotherapy in hypertensive patients.
- Initiating combination therapy may be more beneficial for hypertensive patients with diabetes to achieve target SBP.
- Evidence supports early consideration of combination therapy for improved hypertension control in diabetic populations.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...